|
1
|
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML.
|
Blood
|
2006
|
2.06
|
|
2
|
Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors.
|
PLoS One
|
2010
|
1.41
|
|
3
|
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia.
|
Blood
|
2006
|
1.41
|
|
4
|
The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia.
|
J Clin Invest
|
2012
|
1.24
|
|
5
|
Cryptic chromosome 9q34 deletion generates TAF-Ialpha/CAN and TAF-Ibeta/CAN fusion transcripts in acute myeloid leukemia.
|
Haematologica
|
2007
|
1.03
|
|
6
|
Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis.
|
Blood
|
2003
|
0.99
|
|
7
|
Identification of AML1-ETO modulators by chemical genomics.
|
Blood
|
2009
|
0.97
|
|
8
|
Selective HDAC1/HDAC2 inhibitors induce neuroblastoma differentiation.
|
Chem Biol
|
2013
|
0.92
|
|
9
|
Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia.
|
Lancet Oncol
|
2006
|
0.84
|
|
10
|
Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testes.
|
J Clin Oncol
|
2003
|
0.82
|
|
11
|
e6a2 BCR/ABL1 fusion with cryptic der(9)t(9;22) deletions in a patient with chronic myeloid leukemia.
|
Haematologica
|
2005
|
0.82
|
|
12
|
Constitutive phosphorylation of Janus kinase 2 in the GL15 glioblastoma derived human cell line.
|
Oncol Rep
|
2007
|
0.78
|
|
13
|
Acute lymphoblastic leukaemia in Noonan syndrome.
|
Br J Haematol
|
2006
|
0.78
|
|
14
|
Angiopoietins expression by human myeloma cells.
|
Haematologica
|
2003
|
0.75
|